People · Operator
Named in public records as an officer, director or promoter · active 2017–2017 · Pharma, Other Energy
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Colorado Therapeutics LLC | — | Pharma | Series A | $6.9M | $79.6M | 2017 |
| Glseq, Llc | — | Other Energy | Seed | $2.9M | $19.5M | 2017 |
James Gleason at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Gleason on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Christopher Gleason | 1 | 35 |
| William Jackson | 1 | 8 |
| James Gleeson | 1 | 1 |
| Thomas Raegan | 1 | 1 |
| Eric Schabule | 1 | 1 |
| Joseph Horn | 1 | 1 |
| Eugene Gleason | 1 | 1 |
| Patrick Gleason | 1 | 1 |
| James F. Gleason | 1 | 1 |
| Thomas Reagan | 1 | 1 |
| Eric Schauble | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.